Our Partners
The Private GP Group is committed to providing our patients with the highest quality of care, which includes access to cutting-edge diagnostic testing for various conditions. To ensure that our patients receive the most innovative and accurate testing available, we have established partnerships with leading external companies in the field of diagnostic medicine.
Who we work with...
TruCheck Early Cancer Screening Blood Test
TruCheck Early Cancer Screening blood test is a thorough check for the existence of cancer in your body, identifying which type of cancer(s) you have, and from which organ they have originated. Ideal as part of an annual health check up, this test will help you understand whether you currently have cancer or not, and if you do – where tumours are located for rapid treatment.
Everything Genetic: Genetic Risk Testing For Cancer
Everything Genetic helps you to understand your personal genetic risk of developing common cancers to help guide better healthcare decisions with the support of pre and post-test clinical support. Their clinical-grade genetic cancer testing to help you and your clinician make informed screening, prevention, and treatment decisions.
The Liver Clinic: FribroScan & de-liver-ance
A FibroScan is a safe and effective way used for early detection for signs of liver problems. If detected, a fatty liver can be reversible as long as lifestyle and dietary changes have been implemented. de-liver-ance promotes optimal liver health. It works by stimulating the liver’s natural processes.de-liver-ance helps to reduce cholesterol levels by up to 30% and fatty liver levels by up to 50%.
Stockholm 3 Test: Prostate Cancer Early Detection
Stockholm3 combines PSA with 4 other protein markers and 101 genetic markers for a more accurate risk calculation compared to PSA alone. The results are personalised based on age and family history, providing individualised risk assessment. This approach ensures that individuals with high-risk but low PSA levels are identified early through an MRI, preventing late diagnoses, and expanding treatment options.
